Literature DB >> 24046442

Activity-dependent secretion of progranulin from synapses.

Eugenia Petoukhov1, Sarah Fernando, Fergil Mills, Farhan Shivji, Diana Hunter, Charles Krieger, Michael A Silverman, Shernaz X Bamji.   

Abstract

The secreted growth factor progranulin (PGRN) has been shown to be important for regulating neuronal survival and outgrowth, as well as synapse formation and function. Mutations in the PGRN gene that result in PGRN haploinsufficiency have been identified as a major cause of frontotemporal dementia (FTD). Here we demonstrate that PGRN is colocalized with dense-core vesicle markers and is co-transported with brain-derived neurotrophic factor (BDNF) within axons and dendrites of cultured hippocampal neurons in both anterograde and retrograde directions. We also show that PGRN is secreted in an activity-dependent manner from synaptic and extrasynaptic sites, and that the temporal profiles of secretion are distinct in axons and dendrites. Neuronal activity is also shown to increase the recruitment of PGRN to synapses and to enhance the density of PGRN clusters along axons. Finally, treatment of neurons with recombinant PGRN is shown to increase synapse density, while decreasing the size of the presynaptic compartment and specifically the number of synaptic vesicles per synapse. Together, this indicates that activity-dependent secretion of PGRN can regulate synapse number and structure.

Entities:  

Keywords:  Activity; Frontotemporal dementia; Hippocampal culture; Progranulin; Protein trafficking; Secretion; Synapses

Mesh:

Substances:

Year:  2013        PMID: 24046442     DOI: 10.1242/jcs.132076

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  23 in total

1.  Genetic Regulation of Neuronal Progranulin Reveals a Critical Role for the Autophagy-Lysosome Pathway.

Authors:  Lisa P Elia; Amanda R Mason; Amela Alijagic; Steven Finkbeiner
Journal:  J Neurosci       Date:  2019-01-29       Impact factor: 6.167

2.  Stochastic Subcellular Organization of Dense-Core Vesicles Revealed by Point Pattern Analysis.

Authors:  Benjamin J Robinson; Bogdan Stanisavljevic; Michael A Silverman; Bethe A Scalettar
Journal:  Biophys J       Date:  2016-08-23       Impact factor: 4.033

3.  Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia.

Authors:  Andrew E Arrant; Anthony J Filiano; Daniel E Unger; Allen H Young; Erik D Roberson
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

Review 4.  Progranulin, lysosomal regulation and neurodegenerative disease.

Authors:  Aimee W Kao; Andrew McKay; Param Priya Singh; Anne Brunet; Eric J Huang
Journal:  Nat Rev Neurosci       Date:  2017-04-24       Impact factor: 34.870

5.  Progranulin Gene Therapy Improves Lysosomal Dysfunction and Microglial Pathology Associated with Frontotemporal Dementia and Neuronal Ceroid Lipofuscinosis.

Authors:  Andrew E Arrant; Vincent C Onyilo; Daniel E Unger; Erik D Roberson
Journal:  J Neurosci       Date:  2018-01-29       Impact factor: 6.167

Review 6.  Approaches to develop therapeutics to treat frontotemporal dementia.

Authors:  Lisa P Elia; Terry Reisine; Amela Alijagic; Steven Finkbeiner
Journal:  Neuropharmacology       Date:  2020-01-08       Impact factor: 5.250

7.  PGRN Is Associated with Late-Onset Alzheimer's Disease: a Case-Control Replication Study and Meta-analysis.

Authors:  Hui-Min Xu; Lin Tan; Yu Wan; Meng-Shan Tan; Wei Zhang; Zhan-Jie Zheng; Ling-Li Kong; Zi-Xuan Wang; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2016-01-28       Impact factor: 5.590

8.  Progranulin: Functions and neurologic correlations.

Authors:  Ryan A Townley; Bradley F Boeve; Eduardo E Benarroch
Journal:  Neurology       Date:  2017-12-20       Impact factor: 9.910

9.  Therapeutic intraspinal stimulation to generate activity and promote long-term recovery.

Authors:  Sarah E Mondello; Michael R Kasten; Philip J Horner; Chet T Moritz
Journal:  Front Neurosci       Date:  2014-02-27       Impact factor: 4.677

10.  Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.

Authors:  Jackalina M Van Kampen; David Baranowski; Denis G Kay
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.